Skip to content
Inciteful Med

The Genetics of Huntington Disease: HTT Gene and CAG Repeats

Last updated:

Huntington disease is caused by an abnormally high number of CAG repeats (36 or more) in the HTT gene. This mutation produces a toxic protein that damages the brain's striatum. The length of the CAG repeat helps predict whether and when a person will develop symptoms.

Key Takeaways

  • • A CAG repeat count of 40 or more in the HTT gene means Huntington disease symptoms will eventually develop.
  • • Counts between 36 and 39 indicate reduced penetrance, meaning symptoms may never develop or may start later in life.
  • • The mutant huntingtin protein misfolds and clumps together, damaging a vulnerable brain region called the striatum.
  • • Genetic anticipation can cause the CAG repeat count to grow when passed from parent to child, often leading to earlier symptom onset.
  • • Somatic expansion causes the CAG repeat count to continue growing inside brain cells over a person's lifetime, which speeds up disease progression.

The genetic foundation of Huntington’s Disease (HD) is centered on a single gene called HTT and a specific repeating pattern within it known as CAG repeats. Understanding your genetic test results involves looking at these repeats as a scale that helps doctors predict risk and potential timing of symptoms.

The CAG Repeat Scale

Every person has two copies of the HTT gene, which provides instructions for making the huntingtin protein [1]. Within this gene, three chemical building blocks—Cytosine, Adenine, and Guanine (CAG)—repeat over and over [2]. Your “CAG number” is simply a count of how many times this sequence repeats.

CAG Repeat Count Classification What it Means
26 or fewer Normal Range You will not develop HD and cannot pass it to children [1].
27 to 35 Intermediate You will not develop HD, but there is a small risk the count could grow when passed to a child [1].
36 to 39 Reduced Penetrance You may or may not develop symptoms. If you do, they often start much later in life [1][3].
40 or more Full Penetrance Symptoms will eventually develop if a person lives a normal lifespan [1].
60 or more Juvenile HD Symptoms often begin before age 20 and may look different than adult-onset HD [1].

The “Sticky” Mutant Protein

When the CAG repeat count is too high (36+), the body produces a mutant huntingtin protein (mHTT) [4].

  • A “Toxic Gain”: Think of the normal protein as a precision tool. The mutant version has an extra-long “sticky” tail [4]. This makes the protein misfold and clump together into inclusions (tangled knots) [4].
  • Interference: These knots act like “cellular clutter,” disrupting how the cell creates energy, cleans up waste, and communicates with other cells [4][5].

Why the Striatum?

While the mutant protein is found throughout the body, it is particularly destructive to a brain region called the striatum [6]. This area acts as the brain’s “dispatch center” for movement and mood. The neurons here, known as medium spiny neurons, appear to be uniquely vulnerable to the toxic effects of mHTT, leading to the characteristic movement and emotional symptoms of HD [6][1].

Two Types of Expansion

There are two ways the CAG repeat count can change, which is why HD can vary so much:

  1. Genetic Anticipation (Intergenerational): When the gene is passed from parent to child, the CAG count can grow [7]. This is called anticipation and often results in earlier onset in the next generation [8]. This growth is much more common when the gene is inherited from a father [9][10].
  2. Somatic Expansion (In the Brain): Even after birth, the CAG count can continue to grow inside your own brain cells over your lifetime [11]. This “internal” growth is now considered a major driver of how quickly the disease progresses once it starts [12][13].

What HD is Not

It is important to remember that HD is not a “contagious” disease, nor is it caused by lifestyle choices or environment. It is a strictly inherited condition where the primary driver is the length of the CAG repeat you were born with, combined with how that repeat changes in your brain over time [4][13].

Frequently Asked Questions

What is a normal CAG repeat count for the HTT gene?
A CAG repeat count of 26 or fewer is considered normal. This means you will not develop Huntington disease and cannot pass the mutated gene to your children.
What does a CAG repeat count of 40 or more mean?
A count of 40 or more falls into the full penetrance category. This means a person will eventually develop symptoms of Huntington disease if they live a normal lifespan.
What does reduced penetrance mean in Huntington disease testing?
Reduced penetrance means you have a CAG repeat count between 36 and 39. In this range, you may or may not ever develop symptoms, and if you do, they typically start much later in life.
What is genetic anticipation in Huntington disease?
Genetic anticipation occurs when the CAG repeat count grows as the HTT gene is passed from parent to child. This often causes symptoms to start at an earlier age in the next generation, especially if the gene is inherited from the father.
Why does Huntington disease mainly affect the brain?
While the mutated protein is found throughout the body, it is especially destructive to a brain region called the striatum. The neurons in this area are uniquely vulnerable to the toxic protein clumps, leading to changes in movement and mood.

Questions for Your Doctor

  • • What is my specific CAG repeat count, and what does it indicate about my risk of developing symptoms?
  • • Can you explain why my family history might show earlier onset in children compared to their fathers?
  • • What is the current understanding of 'somatic expansion' in my case, and does it affect how we monitor my health?
  • • Are there specific brain imaging markers you look for in the striatum to track disease progression?

Questions for You

  • • Have I noticed any subtle changes in my movement or mood that might be related to my genetic results?
  • • How do I feel about knowing my CAG repeat number—does it help me plan for the future, or does it feel overwhelming?
  • • Have I discussed my genetic results with my family, especially considering the pattern of 'anticipation'?
  • • What are my goals for managing my health now that I understand the genetic basis of HD?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Huntington's Disease: A Report of an Interesting Case and Literature Review.

    Sharma PK, Aram A, Polaka Y, Pandian V

    Cureus 2024; (16(3)):e55443 doi:10.7759/cureus.55443.

    PMID: 38567236
  2. 2

    Therapeutic Advances for Huntington's Disease.

    Kumar A, Kumar V, Singh K, et al.

    Brain sciences 2020; (10(1)) doi:10.3390/brainsci10010043.

    PMID: 31940909
  3. 3

    Mutant huntingtin protein decreases with CAG repeat expansion: implications for therapeutics and bioassays.

    Landles C, Osborne GF, Phillips J, et al.

    Brain communications 2024; (6(6)):fcae410 doi:10.1093/braincomms/fcae410.

    PMID: 39713241
  4. 4

    Huntington's Disease: Complex Pathogenesis and Therapeutic Strategies.

    Tong H, Yang T, Xu S, et al.

    International journal of molecular sciences 2024; (25(7)) doi:10.3390/ijms25073845.

    PMID: 38612657
  5. 5

    Ubiquitin-modifying enzymes in Huntington's disease.

    Sap KA, Geijtenbeek KW, Schipper-Krom S, et al.

    Frontiers in molecular biosciences 2023; (10()):1107323 doi:10.3389/fmolb.2023.1107323.

    PMID: 36926679
  6. 6

    Cell Replacement Therapy for Huntington's Disease.

    Monk R, Connor B

    Advances in experimental medicine and biology 2020; (1266()):57-69 doi:10.1007/978-981-15-4370-8_5.

    PMID: 33105495
  7. 7

    Repeat expansion diseases.

    Paulson H

    Handbook of clinical neurology 2018; (147()):105-123 doi:10.1016/B978-0-444-63233-3.00009-9.

    PMID: 29325606
  8. 8

    [Identification of new factors inducing CTG.CAG repeat contractions in Myotonic Dystrophy type 1].

    de Pontual L, Gourdon G, Tomé S

    Medecine sciences : M/S 2021; (37 Hors série n° 1()):6-10 doi:10.1051/medsci/2021182.

    PMID: 34878385
  9. 9

    CAG repeat instability in embryonic stem cells and derivative spermatogenic cells of transgenic Huntington's disease monkey.

    Khampang S, Parnpai R, Mahikul W, et al.

    Journal of assisted reproduction and genetics 2021; (38(5)):1215-1229 doi:10.1007/s10815-021-02106-3.

    PMID: 33611676
  10. 10

    Genetic Contributors to Intergenerational CAG Repeat Instability in Huntington's Disease Knock-In Mice.

    Neto JL, Lee JM, Afridi A, et al.

    Genetics 2017; (205(2)):503-516 doi:10.1534/genetics.116.195578.

    PMID: 27913616
  11. 11

    Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington's disease.

    O'Reilly D, Belgrad J, Ferguson C, et al.

    Molecular therapy : the journal of the American Society of Gene Therapy 2023; (31(6)):1661-1674 doi:10.1016/j.ymthe.2023.05.006.

    PMID: 37177784
  12. 12

    Antisense oligonucleotide-mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington's disease iPSC-derived striatal neurons.

    Bunting EL, Donaldson J, Cumming SA, et al.

    Science translational medicine 2025; (17(785)):eadn4600 doi:10.1126/scitranslmed.adn4600.

    PMID: 39937881
  13. 13

    A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease.

    Aldous SG, Smith EJ, Landles C, et al.

    Brain : a journal of neurology 2024; (147(5)):1784-1798 doi:10.1093/brain/awae063.

    PMID: 38387080

This page explains the genetics of Huntington disease for educational purposes. Your medical geneticist or neurologist is the best source for interpreting your specific genetic test results.

Stay up to date

Get notified when new research about Huntington disease is published.

No spam. Unsubscribe anytime.